FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Fresenius Kabi Morphine Sulfate Injection Recall

Morphine Sulfate Injection, USP, 2 mg per mL, 1 mL single dose vial, Rx only, Fresenius…

Fresenius Kabi USA LLC · Melrose Park, IL

Risk level
Class II
Reported by FDA
Oct 6, 2021
Recall ID
D-0856-2021
Check your lot numberHow we source this data

Summary

Fresenius Kabi recalled Morphine Sulfate Injection starting Sep 17, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0856-2021 on Oct 6, 2021. Reason: Defective container: Cracked vials leading to lack of sterility assurance. Status: Terminated.

Why it was recalled

Defective container: Cracked vials leading to lack of sterility assurance

Product description

Morphine Sulfate Injection, USP, 2 mg per mL, 1 mL single dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-452-01. 25 vials per tray packaged 18 trays per shipper

Lot numbers, UPCs & expiration codes

Lot # 6023731, 6023732, Exp 03/2023; 6024172, 6024260, Exp 06/2023

Where it was sold

U.S.A. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0856-2021
Classification
Class II
Status
Terminated
Recall initiated
Sep 17, 2021
FDA report date
Oct 6, 2021
Quantity
963000 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Fresenius Kabi USA LLC

Original FDA data

Every field from FDA enforcement report D-0856-2021, exactly as published.

Show all FDA fields
City
Melrose Park
State
IL
Status
Terminated
Country
United States
Event ID
88698
Address
2020 N Ruby St
Code information
Lot # 6023731, 6023732, Exp 03/2023; 6024172, 6024260, Exp 06/2023
Postal code
60160-1112
Report date
Oct 6, 2021
Product type
Drugs
Recall number
D-0856-2021
Classification
Class II
Recalling firm
Fresenius Kabi USA LLC
Product quantity
963000 vials
Termination date
Jun 20, 2023
Reason for recall
Defective container: Cracked vials leading to lack of sterility assurance
Voluntary / mandated
Voluntary: Firm initiated
Product description
Morphine Sulfate Injection, USP, 2 mg per mL, 1 mL single dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-452-01. 25 vials per tray packaged 18 trays per shipper
Distribution pattern
U.S.A. Nationwide
Recall initiation date
Sep 17, 2021
Initial firm notification
Letter
Center classification date
Sep 27, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0856-2021, published Oct 6, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls